Betty Z. Benedict Endowment of $2 Million to SCTC:

SCTC - Scleroderma Clinical Trials Consortium

Our Misson

The SCTC is an international consortium representing the vast majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis).  The goal of the SCTC is to conduct, sponsor, or facilitate clinical research projects that lead to advances in the management, treatment, and outcomes of patients with scleroderma.  The SCTC aims to represent the views and interests of its membership regarding the performance of clinical research in scleroderma.  The SCTC seeks to ensure that research in scleroderma adheres to high standards for design, conduct, and reporting of results.  The SCTC is particularly focused on improving and developing outcome measures for clinical trials and observational studies, participating in the design and conduct of clinical trials and observational studies, and helping to improve the efficiency of clinical trials.  The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.


Upcoming Meetings

SCTC's Annual General Meeting 2022 - Live!

November 11th, 2022 from 6:30pm to 8:30pm EST
Rubenstein Auditorium, Smilow Translational Research Building
University of Pennsylvania
3600 Convention Blvd.
Philadelphia, PA USA

Invitation to the entire SCTC membership, as well as our Industry Roundtable members, to join us for our first back-to-live annual general meeting!
Working Group Meetings will be held for a maximum of 60 minutes from 16h30 to 17h30, and dinner will be served before the main meeting.

SCTC Roundtable Meeting

Hybrid - Live and Virtual!

December 9th, 2022
9h00 to 12h00 EST in Philadelphia, PA

Invitation to the entire SCTC membership, as well as our Industry Roundtable members, to join us for our next Roundtable meeting being held in person and virtually.
Agenda to come.

For registration and any other relevant information, please contact Adara Borys at

Find out about the SCTC Benedict Visiting Fellowship Programme

Congratulations to the Betty Z. Benedict Grant winner of 2021!
This grant is co-sponsored by the Scleroderma Research Foundation.

Congratulations to the SCTC 2022 Working Group Grant Winners!

Get Involved with SCTC

2021 Betty Z. Benedict Grant for Proposals to Advance the Science of Outcome Measures in Systemic Sclerosis

Become a Member of SCTC

Please join us. There are two types of Membership to choose from:

>> Full member

>> Provisional Member

Donate to SCTC

Donate today to help SCTC and its mission to support research to establish standard outcome measures for clinical treatment trials so that results can be compared over time and over different patient groups.

Pay Membership Fees

If you are a newly accepted member of the SCTC, please select Initial Fee at $250.00 USD.
If you are a returning member of the SCTC, please select the option of Annual Fee at $200.00 USD.
If your institution is unable to use PayPal, please contact

Membership Fees

© 2022 Scleroderma Clinical Trials Consortium. Designed By Kangablu Ltd